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Concise synthesis of rare pyrido[1,2-a]pyrimidin-
2-ones and related nitrogen-rich bicyclic scaﬀolds
with a ring-junction nitrogen†
T. A. Alanine,a,b W. R. J. D. Galloway,a S. Bartlett,a J. J. Ciardiello,a T. M. McGuireb and
D. R. Spring*a
Pyrido[1,2-a]pyrimidin-2-ones represent a pharmaceutically interesting class of heterocycles. The structu-
rally related pyrido[1,2-a]pyrimidin-4-ones are associated with a broad range of useful biological pro-
perties. Furthermore, quinolizinone-type scaﬀolds of these sorts with a bridgehead nitrogen are expected
to display interesting physico–chemical properties. However, pyrido[1,2-a]pyrimidin-2-ones are largely
under-represented in current small molecule screening libraries and the physical and biological properties
of the pyrido[1,2-a]pyrimidin-2-one scaﬀold have been poorly explored (indeed, the same can be said for
unsaturated bicyclic compounds with a bridgehead nitrogen in general). Herein, we report the develop-
ment of a new strategy for the concise synthesis of substituted pyrido[1,2-a]pyrimidin-2-ones from readily
available starting materials. The synthetic route involved the acylation of the lithium amide bases of
2-aminopyridines with alkynoate esters to form alkynamides, which were then cyclised under thermal con-
ditions. The use of lithium amide anions ensured excellent regioselectivity for the 2-oxo-isomer over
the undesired 4-oxo-isomer, which oﬀers a distinct advantage over some existing methods for the synthesis
of pyrido[1,2-a]pyrimidin-2-ones. Notably, diﬀerent aminoazines could also be employed in this approach,
which enabled access to several very unusual bicyclic systems with higher nitrogen contents. This method-
ology thus represents an important contribution towards the synthesis of pyrido[1,2-a]pyrimidin-2-ones and
other rare azabicycles with a ring-junction nitrogen. These heterocycles represent attractive structural tem-
plates for drug discovery.
Introduction
Heterocyclic ring systems are the core scaﬀolds of a large pro-
portion of all pharmaceuticals and agrochemicals.1–3 However,
heterocyclic chemical space has, to date, been explored in an
uneven and unsystematic fashion.2,4 Chemists have largely
focused upon only a small subset of heterocyclic scaﬀolds,
generally those that are both synthetically facile and have
proven biological relevance.4 Unsurprisingly, there remains
intense interest in the synthesis of both novel heterocyclic
scaﬀolds and also unusual ring systems that have been largely
underexploited in drug and agrochemical discovery.2,5–8 One
class of uncommon heterocycles are the pyrido[1,2-a]pyrimi-
din-2-ones (compounds based around scaﬀold 1, Fig. 1). Qui-
nolizinone-type scaﬀolds of these sorts have elicited interest
within the pharmaceutical industry due to reports of encoura-
ging biological activities and attractive predicted physico–
chemical properties (such as high polarity and aqueous
Fig. 1 (a) The pyrido[1,2-a]pyrimidin-2-one core (1) and its dipolar
canonical form. (b) The pyrido[1,2-a]pyrimidin-4-one core (2) and some
examples of biologically active compounds that are based around this
ring system. Compound 3 is an antiulcerative agent15 and compound 4
is an inhibitor of bacterial quorum sensing.16
†Electronic supplementary information (ESI) available: Experimental procedures
and characterisation data. See DOI: 10.1039/c5ob01784j
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solubility compared to their non-nitrogenated analogues) as a
result of their polar zwitterionic character (Fig. 1).1,9–12 The
regioisomeric pyrido[1,2-a]pyrimidin-4-ones are associated
with a broad range of useful biological properties and numer-
ous synthetic routes towards substituted derivatives of this
scaﬀold are available.9,12,13 In contrast, pyrido[1,2-a]pyrimidin-
2-ones have been considerably less well studied.9,12,14 The rela-
tive scarcity of molecules based around the pyrido[1,2-a]pyri-
midin-2-one scaﬀold can be attributed to a comparative lack of
general and flexible methods for their construction. Existing
synthetic strategies suﬀer from various drawbacks (vide infra).
Thus, there is a need for new strategies to generate diﬀerent
pyrido[1,2-a]pyrimidin-2-ones so that the biological and
physico–chemical properties of this heterocyclic system can be
further investigated.
We targeted the development of a more robust and general
method for the synthesis of pyrido[1,2-a]pyrimidin-2-one
derivatives. It was also hoped that the new methodology would
enable access to other related quinolizinone-type systems with
higher nitrogen contents; such very rare derivatives would be
expected to be even more polar than pyrido[1,2-a]pyrimidin-2-
ones and thus may have valuable properties such as enhanced
aqueous solubility.
Reported methods for the synthesis of pyrido[1,2-a]pyrimi-
din-2-ones include:9,12 (i) the cyclisation of 2-aminopyridine
with ethyl cyanoacetate at high temperature and pressure;17 (ii)
the cyclisation of 2-aminopyridine with the Vilsmeier-Haack
reagent;18 (iii) the reaction of 2-aminopyridines with hex-2-en-
4-yne-1,6-dioate or allene-1,3-dicarboxylic esters;19 (iv) the acid-
catalysed cyclisation of N-acetoacetylated 2-amino pyridines/
picolines/quinolones19 and; (v) the addition of 2-aminopyri-
dines to Baylis-Hillman acetates.20 These strategies all suﬀer
from various drawbacks, including a restricted substrate
scope, the need for harsh reaction conditions and poor regio-
control (generation of mixtures of the isomeric 2-oxo and
4-oxo-derivatives 1 and 2).9,12 The most commonly employed
method for the synthesis of pyrido[1,2-a]pyrimidin-2-one
derivatives (of the general form 5) is the one-pot thermal cycli-
sative condensation of 2-aminopyridine derivatives 6 with acti-
vated alkynoates 7, typically carried out under neutral
conditions (Scheme 1).9,12,21–24 In principle, this approach has
several attractive features. It is conceptually straightforward,
step-eﬃcient, and proceeds from readily-available starting
materials. Furthermore, since the approach is inherently
modular in nature it would be expected that a range of novel
analogues could be accessed through variation in the building
blocks used. Unfortunately, the current substrate scope is
limited to 2-aminopyridine derivatives and aminoquinoline
and undesired side product formation has been reported.9,12,25
In addition, there are potential regioselectivity issues that
could arise as a consequence of the fact that the 2-aminopyri-
dine component has two diﬀerent nucleophilic nitrogen
centres and there are two possible modes of addition to the
alkynoate component (direct or conjugate); in principle, both
of the isomeric 2-oxo and 4-oxo-derivatives can be generated
(vide infra).25 Herein, we describe the development of a new
Scheme 1 Synthesis of pyrido[1,2-a]pyrimidin-2-ones and related derivatives from aminoazines and alkynoate esters. aNumber ‘substances’
retrieved from a ‘Chemical Structure Substructure’ search with ‘Lock ring fusion or formation’ selected (August 2015). Data for the number of sub-
stances found are reported in the form: conventional substructure (closely associated tautomers and zwitterions, loosely associated tautomers and
zwitterions, other).
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strategy for the synthesis of pyrido[1,2-a]pyrimidin-2-ones and
related structures of the general form 8 from aminoazines 9
and alkynoate esters 7 which is based around this general
approach (Scheme 1). The novelty of the new strategy centres
on the use of a “defined” two-step procedure that involves acy-
lation of the lithium amide bases of aminoazines with alkyno-
ate esters to form alkynamides 10, which can then be cyclised
under thermal conditions. Compared to one-pot thermal cycli-
sative condensation methods involving the combination of
aminoazines and alkynoate esters, this new procedure oﬀers a
broader substrate scope; several previously unreported substi-
tuted pyrido[1,2-a]pyrimidin-2-one derivatives could be
accessed using this new methodology, together with several
extremely rare scaﬀolds with higher nitrogen contents (of the
general forms 11–15) through the use of the corresponding
aminoazine substrates with higher nitrogen contents (see
Scheme 1 for data). Excellent regioselectivity for the desired
2-oxo-isomers of the bicyclic scaﬀolds over the undesired
4-oxo-isomers was observed in all cases. This new methodology
thus represents an important contribution towards the syn-
thesis of pyrido[1,2-a]pyrimidin-2-ones and other rare azabi-
cycles with a ring-junction nitrogen. These heterocycles
represent attractive structural templates for drug discovery,
oﬀering access to underexplored, yet biologically interesting
chemical space and thus the potential to secure novel intellec-
tual property.
Results and discussion
Outline of the synthetic strategy
The exact mechanistic pathway of the cyclisative condensation
of 2-aminopyridines 16 with activated alkynoates 7 to form
pyrido[1,2-a]pyrimidin-2-ones 17 under typically employed
neutral reaction conditions is not known. 2-Aminopyridines 16
are potentially nucleophilic at both the endocyclic pyridine
nitrogen and the exocyclic amine nitrogen. In principle, either
nitrogen centre could react first with the alkynoate, with direct
and conjugate modes of addition possible in each case
(Scheme 2, illustrated for 2-aminopyridines 16).26 In the case
of initial reaction at the endocyclic pyridine nitrogen, conju-
gate addition would lead to intermediate 18 (Scheme 2, path
A). Subsequent intramolecular lactam formation involving the
2-amino group would then furnish the pyrido[1,2-a]pyrimidin-
2-one system 17. In the case of initial reaction at the exocyclic
amine nitrogen, the pyrido[1,2-a]pyrimidin-2-one scaﬀold 17
would result from direct addition to the alkynoate to form 19
(Scheme 2, path B) followed by intramolecular conjugate
addition of the endocyclic pyridine nitrogen. Under typically
employed neutral/mildly basic conditions, it might be antici-
pated that reaction at the pyridine nitrogen would occur first
since 2-aminopyridines 16 are known to typically react with
electrophiles preferentially at the endocyclic pyridine nitrogen
centre27–30 (Scheme 2, paths A and C). Indeed, there is some
evidence that the first step of the reaction sequence is the con-
jugate addition of the pyridine nitrogen of 16 to alkynoate 7
(Scheme 2, path A).9
However, initial reaction at either amine centre could also
lead to the formation of the isomeric pyrido[1,2-a]pyrimidin-4-
one scaﬀold 20. Direct addition of the pyridine nitrogen of 16
to the alkynoate 7 would furnish intermediate 21 (Scheme 2,
path C); subsequent intramolecular conjugate addition of the
exocyclic amine would then yield the 4-oxo scaﬀold 20. The
4-oxo scaﬀold 20 would also be the predicted product if the
exocyclic amine adds initially to the alkynoate in a conjugate
fashion to form 22 (Scheme 2, path D). Thus, in principle,
both of the isomeric 2-oxo and 4-oxo-derivatives can be
accessed by combination of aminopyridine derivatives and
alkynoates 7.
Aminoazine substrates with higher nitrogen contents (such
as diazines and triazines) would be expected to be inherently
less nucleophilic than 2-aminopyridines 16. Thus, it would be
Scheme 2 Potential mechanistic pathways leading to pyrido[1,2-a]pyrimidin-2-ones 17 and pyrido[1,2-a]pyrimidin-4-ones 20 from 2-aminopyri-
dines 16 and alkynoates 7. An analogous set of pathways can be envisaged for the reaction of other aminoazine derivatives with 7 (not shown).
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anticipated that they would be expected to be considerably less
reactive with alkynoates 7 under the neutral conditions typi-
cally employed in reactions of this sort, which may explain why
they have been largely unexplored in this context. We hypo-
thesised that this issue could be addressed through the use of
basic reaction conditions, specifically the addition of alkyno-
ate 7 to a pre-formed solution of the aminoazine substrate 9.
The use of basic conditions would provide access to the corres-
ponding amide anion, which would be expected to be substan-
tially more reactive than the parent amine. Subsequent
electrophilic attack would be expected to occur preferentially
at the exocyclic amino group nitrogen over the endocyclic pyri-
dine nitrogen (deprotonation of the exocyclic amino group is
one method for preferentially directing electrophilic attack
towards the exocyclic nitrogen in heterocyclic amidines such
as 2-aminopyridine27,30). Furthermore, the deprotonated
amide anion would be expected to be a harder nucleophile
than the amino group (present under neutral or mildly basic
conditions) and thus more regioselective for the acyl position
of the alkynoate; that is, analogous to preferential reaction via
path B in Scheme 2 rather than other competing modes of
addition with 7. Isolation of the resulting amide intermediate
10 and subsequent thermal-induced cyclization should then
furnish the azabicyclic framework 8. Thus, we anticipated that
the adoption of this “defined” two-step protocol involving
basic reaction conditions would eﬀectively “bias” reaction pro-
gress towards the 2-oxo products, thereby increasing the regio-
selectivity for the desired 2-oxo isomers, in addition to the
aforementioned expansion in the substrate scope to other
aminoazine substrates.
Synthesis of pyrido[1,2-a]pyrimidin-2-ones and related
nitrogen-rich bicyclic heterocycles
Using 2-aminopyridine 23 as a model substrate, it was found
that deprotonation of the amine group with an excess of
n-butyllithium (nBuLi), lithium diisopropylamide (LDA), or
lithium bis(trimethylsilyl)amide (LiHMDS) at low temperature
followed by addition of alkynoate 24 delivered the desired
amide intermediate 25 (Table 1). In all cases, there was no evi-
dence for conjugate addition to the alkynoate or bis-acylation
of the amino group (as determined by LC-MS analysis of the of
the crude reaction mixtures). Compound 26 was detected as a
by-product in all cases, which presumably resulted from the
conjugate addition of ethoxide to 24.31 The highest level of
conversion was observed with 1.2 equivalents of 24 (Table 1,
entry 3) and 2.1 equivalents of nBuLi; further increases in the
equivalents of 24 (Table 1, entries 4–6) used had little impact
upon reaction conversion, but led to larger amounts of the by-
product 26. Thus, the conditions described in Table 1 entry 3
were chosen for further application.
A selection of readily-available 2-aminopyridines and ami-
noazine substrates was then subjected to the optimised con-
ditions for acylation with ethyl 2-butynoate 24 (Scheme 3).
Pleasingly, amidation was successful with a range of heteroaro-
matic systems 23, 27–42, leading to products 25, 43–58. For
some substrates, treatment with nBuLi led to side reactions
(which appeared to involve displacement or reduction of the
halide functionality), which impacted upon reaction yields; in
these cases, the use of LDA as the base led to cleaner reaction
profiles. For compound 23 and cases where the heteroaromatic
unit bore an electron-releasing substituent (aminoazines 28
and 32), some apparent spontaneous cyclisation of the pre-
sumed amide intermediates was observed under the reaction
conditions (which could be a consequence of increased relative
nucleophilciity of each of the corresponding ring nitrogen
atoms). It was found that the yields for the acylation step were
highest and most reproducible when reaction and purification
were carried out within a six hour time period and solvents
were removed under reduced pressure without heating. For
example, under these circumstances the average yield for the
synthesis of compound 48 over three repeats was 35 ± 4%. A
lower yield (25%) for compound 48 was obtained when the acy-
lation reaction and purification was done over a longer time
period. It was also found that trituration with heptane was a
useful way of obtaining analytically pure material if column
chromatography proved insuﬃcient.
For aminoazine substrates 59–61 the corresponding final
target azabicyclic derivatives 62–64 were isolated exclusively
under the amidation reaction conditions (that is, the pre-
sumed amide intermediates were not detected, Scheme 4). The
yields of these derivatives were low, which could be mainly
attributed to their high aqueous solubilities (likely a result of a
degree of zwitterionic character by analogy with the quinoli-
zin-2-one scaﬀold, see Fig. 1) and thus their poor recoveries
after aqueous work-ups. The facile in situ cyclisation of the pre-
sumed amide intermediate generated from substrate 59 (to
form 62) might be due to the steric influence of the benzyloxy
group, which could potentially force the acetylenic moiety into
close proximity to the pyridine nitrogen and thus encourage
cyclisation. In the case of the amide intermediate generated
from 60 the high propensity to cyclise (to form 63) might be a
kinetic eﬀect, as both nitrogen atoms in the ring could pre-
sumably induce cyclisation (and thus increase the likelihood
of cyclisation). The reaction of 2-aminopyridine 23 with the
Table 1 Optimization of conditions for aminationa
Entry Base
Equivalents
of 24
Conversion
to 25a (%)
By-product
26a (%)
1 LiHMDS 1.2 60 >10
2 LDA 1.2 75 >10
3 nBuLi 1.2 89 >10
4 nBuLi 1.5 >90 23
5 nBuLi 2.0 >90 31
6 nBuLi 2.5 >90 37
a Based on LC-MS analysis of crude reaction mixtures.
Paper Organic & Biomolecular Chemistry
1034 | Org. Biomol. Chem., 2016, 14, 1031–1038 This journal is © The Royal Society of Chemistry 2016
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
N
ov
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
0/
01
/2
01
6 
13
:3
1:
34
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
other readily available alkynoates ethyl 3-phenylbutynoate,
diethyl acetylenedicarboxylate and ethyl 4,4,4-trifluorobut-2-
ynoate (65) was briefly explored. Disappointingly, the acylation
reaction failed with ethyl 3-phenylbutynoate and diethyl-
acetylenedicarboxylate, leading to complex intractable mix-
tures of unidentifiable products.32 In contrast, the reaction of
23 with 65 led to the formation of the final target pyrido[1,2-a]-
pyrimidin-2-one 66 (Scheme 4). This was not altogether unex-
pected, as Harriman et al.9 have previously reported that the
thermal cyclisative condensation of 23 and 65 occurs readily at
room temperature, presumably as a consequence of the elec-
trophilicity of the CF3-bearing carbon.
With amide intermediates 25 and 43–58 in hand, we were
ready to examine the 6-endo-dig cyclisation step in an attempt
to access the corresponding target azabicyclic compounds
(Scheme 5). It was anticipated that cyclisation could be trig-
gered by thermal heating. This was indeed found to be the
case for the majority of the amide substrates, with the rate of
reaction dependant upon both the solvent and temperature
used (reactions were generally found to proceed more quickly
as both the temperature and the dielectric constant of the
solvent was increased). Thermal heating in DMSO at 85 °C was
found to be optimal for the 2-aminopyridine derivatives 25
and 43–51. In the majority of cases reaction times were under
five hours and the yields of the target pyrido[1,2-a]pyrimidin-2-
ones 67–76 were typically good-to-excellent. In all cases there
was no evidence for the formation of the undesired 4-oxo-iso-
meric derivatives. The cyclisation of amide intermediates with
higher nitrogen contents was comparatively sluggish, which
was taken to be indicative of higher activation energy barriers
for these reactions. Pleasingly however, the use of elevated
reaction temperatures and times did enable access to quino-
Scheme 4 Formation of azabicyclic derivatives 62–64 and 66 under
amidation reaction conditions.
Scheme 3 Synthesis of amides 25 and 43–58. aSome cyclised material was observed in the crude material obtained after reaction work-up but this
could not be isolated. bImpure product mixture isolated. Further puriﬁcation by HPLC possible. See ESI† for more details.
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line derivative 80 and compounds 77–79 which are based
around extremely rare nitrogen-rich bicyclic scaﬀolds, again
typically in good-to-excellent yields. In all these reactions there
was no evidence for the formation of the undesired 4-oxo-iso-
meric derivatives. Unfortunately, the cyclisation of aminoazine
amides 54 and 56, which each contain an electron withdraw-
ing substituent, could not be achieved (which presumably can
be explained by the decreased nucleophilicty of the respective
endocyclic nitrogen atoms). Amide 58 also failed to cyclise.33
Conclusions
In conclusion, we have developed a new and modular strategy
for the concise synthesis of pyrido[1,2-a]pyrimidin-2-ones and
related compounds based around bicyclic heterocyclic
scaﬀolds with a ring-junction nitrogen. These rare heterocylic
scaﬀolds have elicited interest from the pharmaceutical indus-
try owing to reports of biological activities and favourable
anticipated physico–chemical properties, yet they remain
largely unexplored, primarily due to problems with their syn-
thetic tractability.
Our strategy is based around the combination of amino-
azines and alkynoate esters, a known and general approach
towards compounds of this sort. The novelty of this new strategy
centres on the adoption of a two-step procedure that involves
the use of the lithium amide anions of the aminoazines. This
ensures excellent regioselectivity for the desired 2-oxo-isomers
of the bicyclic scaﬀolds over the undersired 4-oxo-isomers, a
notable advantage over some existing methodologies. Further-
more, the new protocol allows for an expansion of the substrate
scope of this general synthetic approach; in addition to 2-amino-
azines, we have demonstrated, for the first time, the utilis-
ation of a range of aminoazines with higher nitrogen contents
(aminopyrimidines, aminopyrazines and aminopyridazines).
Consequently, the new protocol allows for access not only to
pyrido[1,2-a]pyrimidin-2-ones, but also a number of very
unusual aza-bicyclic systems with higher nitrogen contents.
Scheme 5 Formation of azabicyclic derivatives 67–80. aImpure product mixture isolated. Further puriﬁcation by HPLC possible. See ESI† for more
details. bSpectroscopically pure material isolated but some degradation observed over time.
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Overall, this new methodology was found to be widely appli-
cable to a range of aminoazines and we believe that it rep-
resents an important contribution towards the synthesis of
pyrido[1,2-a]pyrimidin-2-ones and other rare azabicycles with a
ring-junction nitrogen. It is envisaged that these scaﬀolds
could serve as attractive structural templates in drug discovery
endeavours (for example, as starting fragments in fragment-
based approaches). Crucially in this regard, our methodology
was shown to be tolerant of some functionality in the aminoa-
zine component. This allows for the installation of some syn-
thetic handles in the final aza-bicycles for further potential
elaboration. Studies examining the biological and physico–
chemical properties of the compounds generated in this report
are underway and results will be reported in due course.
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